The challenger. Trails the leader on the balanced score. Its widest win over the field is growth.
The verdict
CTSH leads clearly (66/100 vs ZS 44) under a balanced style, mostly on valuation. But ZS wins on growth, so the comparison turns on what you weight. Switch your goal above and watch the scores move.
THE SCORECARD · FACTOR BY FACTOR · the best value in each row is ticked, and a tie ticks every tied column · weight bar shows how much it counts for your goal
† Balance sheet is scored on 5 peer percentiles (current ratio, quick ratio, net debt/EBITDA, interest coverage and debt/equity). The cell shows one of them, so a column can lead on the printed number and still lose the row.
The letter beside the dividend yield is our dividend-safety grade (A+ to F), a read on how likely that dividend is to be cut. It does not grade the yield.
ValuationCurrently 16/100 (P/E — · EV/EBITDA 111.3). Taking it to 100 would lift the balanced score by 11 points, the biggest single move available.
Total returnCurrently 27/100 (5Y −11%/yr). Taking it to 100 would lift the balanced score by 9 points, the next biggest.
Scores are Tenet composites, 0–100, reweighted for your selected goal. Seven of the eight factors are sector percentiles; analyst sentiment is an absolute curve on forward EPS growth, capped at 100, so two very high-growth names can share the top score. Moat/durability is not scored (qualitative, not measurable). Comparison is decision-support, not a recommendation · past performance does not predict future returns · Not investment advice · prices are each company's own latest close, the newest here being Nov 13, 2026 · valuation, growth, quality and balance scores from the Nov 13, 2026 scoring run · analyst consensus, return, risk and income scores computed Nov 13, 2026.